Share on LinkedInShare on LinkedIn

ARTICLE · 08 JANUARY 2018

Weed Wars: Securities Commissions Weigh In On Aurora/CanniMed Hostile Bid

On November 29, 2017, CanniMed announced that it had adopted a poison pill.

CanadaCorporate/Commercial Law

After a joint hearing in mid-December, the Ontario and Saskatchewan securities commissions released identical orders in respect of the unsolicited take-over bid by Aurora Cannabis Inc. for the issued and outstanding common shares of CanniMed Therapeutics Inc. and CanniMed's use of a shareholder rights plan in response to Aurora's unsolicited offer. Although the reasons of the securities commissions have not yet been released, several important implications have emerged from the orders regarding the use of shareholder rights plans as a deal protection measure.

Background

On November 14, 2017, Aurora disclosed that it had submitted an acquisition proposal to the board of directors of CanniMed to acquire CanniMed in consideration for Aurora shares. In its disclosure, Aurora added that it had entered into irrevocable lock-up agreements with shareholders representing 38% of the issued and outstanding CanniMed shares (collectively, the Locked-Up Shareholders). Under the

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

See more popular content from